The Latest Cardiac and Vascular News
KFAR-SABA, Israel–(BUSINESS WIRE)–CathWorks announced the approval of a new CPT code 0523T for non-invasive, 3D FFRangio™ enabled interpretation of possible atherosclerotic stenosis during coronary angiography interventions. The code issuance is a major step forward in helping physicians objectively and cost-effectively determine if PCI (percutaneous coronary intervention) is indicated and revascularization has occurred in every coronary […]
KFAR SABA, Israel, Oct. 27, 2017 /PRNewswire/ — CathWorks Ltd., a leader in the development of non-invasive Fractional Flow Reserve (FFR) measurements for guiding coronary interventions, announced today the appointment of James M. Corbett as its Chief Executive Officer. Corbett, an industry veteran with broad experience in global commercialization, has served as President, Boston Scientific International, CEO Home Diagnostics, CEO of […]
KFAR SABA, Israel, Oct. 24, 2017 /PRNewswire/ — Cathworks, a leader in the development of non-invasive Fractional Flow Reserve (FFR) measurements for guiding coronary interventions, announced today that the first patient has been enrolled in the FAST-FFR (FFRangio Accuracy vs. STandard FFR) clinical trial. This global pivotal trial is designed to assess the efficacy of FFRangio™ in measuring FFR derived […]
KFAR SABA, Israel, Oct. 2nd, 2017 /PRNewswire/ — CathWorks Ltd., a leader in the development of non-invasive FFR measurements for guiding coronary interventions, today announced the completion of a $15.8M Series B round of financing, led by Quark Venture and Triventures. The syndicate also included Planven Investments, Pontifax, Corundum Open Innovation, and BioStar Venturesas well as a strategic investor. Cathworks’ lead product is a […]
